Related Experiment Video
Updated: Apr 27, 2026
An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
PLC-beta 1 regulates the expression of miR-210 during mithramycin-mediated erythroid differentiation in K562 cells
Alberto Bavelloni1, Alessandro Poli, Roberta Fiume
1SC Laboratory of Musculoskeletal Cell Biology, Rizzoli Orthopedic Institute, Bologna, Italy; Laboratory RAMSES, Rizzoli Orthopedic Institute, Bologna, Italy.
Abstract:
PLC-beta 1 (PLCβ1) inhibits in human K562 cells erythroid differentiation induced by mithramycin (MTH) by targeting miR-210 expression. Inhibition of miR-210 affects the erythroid differentiation pathway and it occurs to a greater extent in MTH-treated cells. Overexpression of PLCβ1 suppresses the differentiation of K562 elicited by MTH as demonstrated by the absence of γ-globin expression. Inhibition of PLCβ1 expression is capable to promote the differentiation process leading to a recovery of γ-globin gene even in the absence of MTH. Our experimental evidences suggest that PLCβ1 signaling regulates erythropoiesis through miR-210. Indeed overexpression of PLCβ1 leads to a decrease of miR-210 expression after MTH treatment. Moreover miR-210 is up-regulated when PLCβ1 expression is down-regulated. When we silenced PKCα by RNAi technique, we found a decrease in miR-210 and γ-globin expression levels, which led to a severe slowdown of cell differentiation in K562 cells and these effects were the same encountered in cells overexpressing PLCβ1. Therefore we suggest a novel role for PLCβ1 in regulating miR-210 and our data hint at the fact that, in human K562 erythroleukemia cells, the modulation of PLCβ1 expression is able to exert an impairment of normal erythropoiesis as assessed by γ-globin expression.
Insights
Phospholipase C-beta 1 (PLCβ1) regulates erythroid differentiation in K562 cells by controlling miR-210 expression. Modulating PLCβ1 impacts erythropoiesis, highlighting its role in this process.
Area of Science:
- Cell Biology
- Molecular Biology
- Hematology
Background:
- Erythroid differentiation is a complex process crucial for oxygen transport.
- Phospholipase C-beta 1 (PLCβ1) and microRNA-210 (miR-210) are implicated in cellular regulation.
- K562 cells are a human erythroleukemia cell line commonly used to study erythropoiesis.
Purpose of the Study:
- To investigate the role of PLCβ1 in regulating erythroid differentiation in K562 cells.
- To determine the relationship between PLCβ1, miR-210, and erythropoiesis.
- To elucidate the signaling pathway involving PLCβ1 and miR-210 in erythroid differentiation.
Main Methods:
- Overexpression and inhibition of PLCβ1 in K562 cells.
- Mithramycin (MTH) treatment to induce erythroid differentiation.
- Quantitative analysis of γ-globin expression.
- RNA interference (RNAi) to silence PKCα.
- Monitoring miR-210 expression levels.
Main Results:
- PLCβ1 overexpression inhibits MTH-induced erythroid differentiation, evidenced by reduced γ-globin expression.
- Inhibition of PLCβ1 promotes erythroid differentiation and γ-globin recovery.
- PLCβ1 modulates miR-210 expression; PLCβ1 overexpression decreases miR-210, while inhibition increases it.
- Silencing PKCα mimics PLCβ1 overexpression effects, reducing miR-210 and γ-globin, and slowing differentiation.
Conclusions:
- PLCβ1 plays a novel inhibitory role in erythroid differentiation of K562 cells, mediated through miR-210.
- The PLCβ1/miR-210 axis is a key regulator of erythropoiesis in this model.
- Modulation of PLCβ1 expression can impair normal erythropoiesis, suggesting therapeutic potential in erythroid disorders.
Related Concept Videos
02:23Master Transcription Regulators
01:22MicroRNAs
01:22MicroRNAs
01:23Negative Regulator Molecules